Tenaya Therapeutics TNYA
NASDAQ TNYA
$0.37 -0.02 (-5.13%)
At close: Nov 10, 2026 · 4:00 PM EST

Tenaya Therapeutics (TNYA) Non Operating Income (2020 - 2026)

Updated

Tenaya Therapeutics' Non Operating Income was $634,000 in Q3 2026, down 4.1% from $661,000 a year earlier and down 8.8% from the prior quarter.

Analysis

Tenaya Therapeutics (TNYA) Non Operating Income (2020 - 2026) Analysis & Trends

On a trailing twelve-month basis, Tenaya Therapeutics' Non Operating Income was $2.72 million through Sep 30, 2026, down 7.7% year-over-year; for FY2025, it was $2.73 million, down 43.3% from FY2024.

  • Non Operating Income shows a five-year compound annual growth rate of 39.5% (FY2020 to FY2025).
  • In earlier years, Non Operating Income was $4.82 million in FY2024 (-32.2%), $7.11 million in FY2023 (+263.4%), $1.96 million in FY2022 and $85,000 in FY2021 (-83.6%).
  • Quarterly Non Operating Income has moved between $13,000 (Q4 2021) and $1.99 million (Q1 2023) over five years.
  • Compared with a year earlier, Non Operating Income was higher in 1 of the last eight quarters, with an average decline of 26.2%.
  • The best year-over-year quarter for Non Operating Income over five years was Q2 2023 (growth of 726.6%); the worst was Q1 2025 (a decline of 56.1%).
  • Per Business Quant data, TNYA's Non Operating Income in the three quarters before Q3 2026 was $695,000 (Q2 2026), $793,000 (Q1 2026) and $600,000 (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Op. Inc. (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -202.00 Mn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 1.63 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -130.00 Mn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 Tenaya Therapeutics 84.33 Mn 17.53 Mn - 634,000.00
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 634,000.00
Jun 30, 2026 695,000.00
Mar 31, 2026 793,000.00
Dec 31, 2025 600,000.00
Sep 30, 2025 661,000.00
Jun 30, 2025 799,000.00
Mar 31, 2025 674,000.00
Dec 31, 2024 816,000.00
Sep 30, 2024 1.08 Mn
Jun 30, 2024 1.39 Mn
Mar 31, 2024 1.53 Mn
Dec 31, 2023 1.51 Mn
Sep 30, 2023 1.78 Mn
Jun 30, 2023 1.84 Mn
Mar 31, 2023 1.99 Mn
Dec 31, 2022 1.03 Mn
Sep 30, 2022 602,000.00
Jun 30, 2022 222,000.00
Mar 31, 2022 98,000.00
Dec 31, 2021 13,000.00
API Access

Tenaya Therapeutics Non Operating Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-income&ticker=TNYA&period=max&api_key=YOUR_API_KEY